Study shows advantages of as-needed administration of Ozurdex in DME

FLORENCE, Italy — As-needed administration of a corticosteroid implant may enhance stability of visual outcomes in patients with diabetic macular edema, according to a study. In phase 3 studies, the Ozurdex dexamethasone implant (Allergan) administered at fixed 6-month intervals proved effective, but a small, gradual decline of vision was seen after the first 3 months as the effects of the drug started wearing off.